FGFR4 and hepatocellular carcinoma: At this point, however, we could not conclude on the reason for these conflicting results on the prognostic implication of FGFR4: these might be related with different methodology (immunohistochemistry vs mRNA expression using NanoString platform) or cancer types (HCC vs iCCA).